ODAN-ERYTHROMYCIN
ODAN LABORATORIES LTD
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ODAN-ERYTHROMYCIN in Canada?
Yes. ODAN-ERYTHROMYCIN 5MG has an active shortage reported to Health Canada (last updated January 10, 2019).
Why is ODAN-ERYTHROMYCIN not available?
The reason the manufacturer reported: Demand increase for the drug.
When will ODAN-ERYTHROMYCIN be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ILOSONE LIQUID 125MG/5ML
ELI LILLY CANADA INC
NOVO-RYTHRO STEARATE TAB 250MG
NOVOPHARM LIMITED
ERYTHROCIN FILMTAB 500MG
ABBOTT LABORATORIES, LIMITED
ILOSONE LIQUID 250MG/5ML
ELI LILLY CANADA INC
NOVO-RYTHRO ESTOLATE SUSPENSION
TEVA CANADA LIMITED
NOVO-RYTHRO ETHYLSUCCINATE PWR 400MG/5ML
NOVOPHARM LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
00641324
Strength
5MG
Dosage Form
OINTMENT
Route
OPHTHALMIC
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.